UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The authors reply

Critical care medicine, 2021-11, Vol.49 (11), p.e1190-e1191

2021

Volltextzugriff (PDF)

Prevalence of Thrombotic Complications in ICU-Treated Patients With Coronavirus Disease 2019 Detected With Systematic CT Scanning

Critical care medicine, 2021-05, Vol.49 (5), p.804-815

2021

Volltextzugriff (PDF)

P1718Veno-arterial ECMO versus Left Impella bleeding complications in cardiogenic shock patients on dual antiplatelet therapy

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

Antibodies against TFPI and protein C are associated with a severe thrombotic phenotype in patients with and without antiphospholipid syndrome

Thrombosis research, 2018-10, Vol.170, p.60-68

2018

Volltextzugriff (PDF)

P1747Heparin anti-Xa assay versus Activated Partial Thromboplastin Time to monitor unfractionated heparin during Extra-Corporeal-Membrane-Oxygenation

European heart journal, 2018-08, Vol.39 (suppl_1)

2018

Volltextzugriff (PDF)

Should we abandon the APTT for monitoring unfractionated heparin?

Thrombosis research, 2017-09, Vol.157, p.157-161

2017

Volltextzugriff (PDF)

Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH: reply

Journal of thrombosis and haemostasis, 2017-01, Vol.15 (1), p.195-197

2017

Volltextzugriff (PDF)

Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism

Journal of thrombosis and haemostasis, 2016-11, Vol.14 (11), p.2177-2186

2016

Volltextzugriff (PDF)

Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience

Thrombosis research, 2016-11, Vol.147, p.32-35

2016

Volltextzugriff (PDF)

Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial

The Lancet. Haematology, 2016-09, Vol.3 (9), p.e426-e436

2016

Volltextzugriff (PDF)

Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2016-08, Vol.14 (8), p.1673-1676

2016

Volltextzugriff (PDF)

Choosing and using non-steroidal anti-inflammatory drugs in haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-03, Vol.22 (2), p.179-187

2016

Volltextzugriff (PDF)

Heparin-induced thrombocytopenia following plasma exchange in patients with demyelinating neurological disease

International journal of laboratory hematology, 2015-08, Vol.37 (4), p.e75-e77

2015

Volltextzugriff (PDF)

Heparin-induced thrombocytopenia following plasma exchange in patients with demyelinating neurological disease

International journal of laboratory hematology, 2015, Vol.37 (4), p.e75-e77

2015

Volltextzugriff (PDF)

Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome

Journal of thrombosis and haemostasis, 2015-07, Vol.13 (7), p.1264-1273

2015

Volltextzugriff (PDF)

Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism

Thrombosis research, 2015-02, Vol.135 (2), p.388-393

2015

Volltextzugriff (PDF)

Anti‐protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome

Journal of thrombosis and haemostasis, 2014-11, Vol.12 (11), p.1801-1809

2014

Volltextzugriff (PDF)

Comparative sensitivity of commonly used thromboplastins to ex vivo therapeutic rivaroxaban levels

Thrombosis and haemostasis, 2014-08, Vol.112 (2), p.421-423

2014

Volltextzugriff (PDF)

Long‐term dual donor derived haematopoietic reconstitution following double unrelated cord blood transplantation – single unit dominance is not always the case

British journal of haematology, 2010-04, Vol.149 (2), p.298-299

2010

Volltextzugriff (PDF)

Long-term dual donor derived haematopoietic reconstitution following double unrelated cord blood transplantation--single unit dominance is not always the case

British journal of haematology, 2010, Vol.149 (2), p.298-299

2010

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(18)
Berichte
(2)

Sprache

Englisch
(20)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

The authors reply

Prevalence of Thrombotic Complications in ICU-Treated Patients With Coronavirus Disease 2019 Detected With Systematic CT Scanning

P1718Veno-arterial ECMO versus Left Impella bleeding complications in cardiogenic shock patients on dual antiplatelet therapy

Antibodies against TFPI and protein C are associated with a severe thrombotic phenotype in patients with and without antiphospholipid syndrome

P1747Heparin anti-Xa assay versus Activated Partial Thromboplastin Time to monitor unfractionated heparin during Extra-Corporeal-Membrane-Oxygenation

Should we abandon the APTT for monitoring unfractionated heparin?

Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH: reply

Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism

Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience

Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial

Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH

Choosing and using non-steroidal anti-inflammatory drugs in haemophilia

Heparin-induced thrombocytopenia following plasma exchange in patients with demyelinating neurological disease

Heparin-induced thrombocytopenia following plasma exchange in patients with demyelinating neurological disease

Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome

Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism

Anti‐protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome

Comparative sensitivity of commonly used thromboplastins to ex vivo therapeutic rivaroxaban levels

Long‐term dual donor derived haematopoietic reconstitution following double unrelated cord blood transplantation – single unit dominance is not always the case

Long-term dual donor derived haematopoietic reconstitution following double unrelated cord blood transplantation--single unit dominance is not always the case

Suchergebnisse filtern